These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37216286)

  • 1. Identification of potent anti-fibrinolytic compounds against plasminogen and tissue-type plasminogen activator employing
    Banerjee S; Mahesh Y; Prabhu D; Sekar K; Sen P
    J Biomol Struct Dyn; 2024 Apr; 42(6):3204-3222. PubMed ID: 37216286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
    Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators.
    Urano S; Metzger AR; Castellino FJ
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2568-71. PubMed ID: 2523073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen and plasmin activity in patients with coronary artery disease.
    Drinane MC; Sherman JA; Hall AE; Simons M; Mulligan-Kehoe MJ
    J Thromb Haemost; 2006 Jun; 4(6):1288-95. PubMed ID: 16706973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of fibrinolysis by C-terminal lysines operates through plasminogen and plasmin but not tissue-type plasminogen activator.
    Silva MM; Thelwell C; Williams SC; Longstaff C
    J Thromb Haemost; 2012 Nov; 10(11):2354-60. PubMed ID: 22974122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired clot lysis by rt-PA catalyzed mini-plasminogen activation.
    Duboscq C; Genoud V; Parborell MF; Kordich LC
    Thromb Res; 1997 Jun; 86(6):505-13. PubMed ID: 9219330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpesviruses enhance fibrin clot lysis.
    Gershom ES; Vanden Hoek AL; Meixner SC; Sutherland MR; Pryzdial EL
    Thromb Haemost; 2012 Apr; 107(4):760-8. PubMed ID: 22318336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of physiological fibrinolysis.
    Lijnen HR; Collen D
    Baillieres Clin Haematol; 1995 Jun; 8(2):277-90. PubMed ID: 7549063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergism of red blood cells and tranexamic acid in the inhibition of fibrinolysis.
    Raska A; Kálmán K; Egri B; Csikós P; Beinrohr L; Szabó L; Tenekedjiev K; Nikolova N; Longstaff C; Roberts I; Kolev K; Wohner N
    J Thromb Haemost; 2024 Mar; 22(3):794-804. PubMed ID: 38016517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of plasminogen binding and fibrinolysis by chloropeptin I.
    Tachikawa K; Hasumi K; Endo A
    Thromb Res; 1997 Sep; 87(6):571-6. PubMed ID: 9330439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of kringles derived from human plasminogen on fibrinolysis in vitro.
    Sugiyama N; Iwamoto M; Abiko Y
    Thromb Res; 1987 Aug; 47(4):459-68. PubMed ID: 2821651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Fibrinolytic System in Health and Disease.
    Kwaan HC
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
    Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
    Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenously generated plasmin at the vascular wall injury site amplifies lysine binding site-dependent plasminogen accumulation in microthrombi.
    Brzoska T; Tanaka-Murakami A; Suzuki Y; Sano H; Kanayama N; Urano T
    PLoS One; 2015; 10(3):e0122196. PubMed ID: 25806939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of plasmin-mediated degradation on fibrinolysis and tissue plasminogen activator diffusion.
    Bannish BE; Paynter B; Risman RA; Shroff M; Tutwiler V
    Biophys J; 2024 Mar; 123(5):610-621. PubMed ID: 38356261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disintegration and reorganization of fibrin networks during tissue-type plasminogen activator-induced clot lysis.
    Meh DA; Mosesson MW; DiOrio JP; Siebenlist KR; Hernandez I; Amrani DL; Stojanovich L
    Blood Coagul Fibrinolysis; 2001 Dec; 12(8):627-37. PubMed ID: 11734662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxynitrite and fibrinolytic system-The effects of peroxynitrite on t-PA-induced plasmin activity.
    Kolodziejczyk-Czepas J; Ponczek MB; Nowak P
    Int J Biol Macromol; 2015 Nov; 81():212-9. PubMed ID: 26234576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
    Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
    Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kringle glycosylation in a modified human tissue plasminogen activator improves functional properties.
    Berg DT; Burck PJ; Berg DH; Grinnell BW
    Blood; 1993 Mar; 81(5):1312-22. PubMed ID: 8382971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.